A Multi-Center, Open-Label Extension Study to Examine the Safety and Tolerability of ACP-103 in the Treatment of Psychosis in Parkinson's Disease

Printer-friendly versionSend by emailPDF version

Name

Acadia Pharmaceuticals, Incorporated

Anticipated Amount

148 940.00

Activity Type

Clinical Trial

Award Type

Contract

Date

July 1, 2012 to May 30, 2015

Award Number

004407-00001

Sponsor Award Number

ACP-103-015

Award Contacts

Name

Bose,Sudeshna C

Title

Principal Investigator

Unit

Neurology

UA@Work is produced by University Communications

888 N. Euclid Ave., Ste. 413 (or) 
P.O. Box 210158, Tucson, AZ 85721

T 520.621.1877  F 520.626.4121

Feedback

2018 © The Arizona Board of Regents on behalf of the University of Arizona